(Q33523284)

English

Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Marianne Stanford

object named as

Marianne M Stanford

5

0 references

7

object named as

John C Bell

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Jari E Heikkilä

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Markus J V Vähä-Koskela

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Janne J Ruotsalainen

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Miika W Martikainen

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J Andrea McCart

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Ari E Hinkkanen

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

6 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

e8603

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

copyright license

Creative Commons Attribution 4.0 International

6 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Malignant astrocytic glioma: genetics, biology, and paths to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

The role of surgery in high-grade glioma--is surgical resection justified? A review of the current knowledge.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Oncolytic viruses in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

In vivo testing of Renilla luciferase substrate analogs in an orthotopic murine model of human glioblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Identification of a cancer stem cell in human brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Intergeneric poliovirus recombinants for the treatment of malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Replicase complex genes of Semliki Forest virus confer lethal neurovirulence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Reovirus therapy of tumors with activated Ras pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

The alphaviruses: gene expression, replication, and evolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Arthropod-borne virus antibodies in sera of residents of Kainji Lake Basin, Nigeria 1980

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Survey for antibodies against arthropod-borne viruses in the sera of indigenous residents of Angola

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

The Virulence of Original and Derived Strains of Semliki Forest Virus for Mice, Guinea-pigs and Rabbits

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

An outbreak of human Semliki Forest virus infections in Central African Republic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

21 June 2018

Reovirus as an oncolytic agent against experimental human malignant gliomas

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

Isolation of Semliki Forest virus from Aedes (Aedimorphus) argenteopunctatus (Theobald) collected in Portuguese East Africa

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

Biodistribution and tumor infectivity of semliki forest virus vectors in mice: effects of re-administration.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0008603

21 January 2018

Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

31 October 2018

Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799335

31 October 2018

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066051

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0008603

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

2010PLoSO...5.8603H

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33523284&oldid=1954173557"